The influence of pH on the molecular degradation mechanism of PLGA

Poly[(rac-lactide)-co-glycolide] (PLGA) is used in medicine to provide mechanical support for healing tissue or as matrix for controlled drug release. The properties of this copolymer depend on the evolution of the molecular weight of the material during degradation, which is determined by the kinetics of the cleavage of hydrolysable bonds. The generally accepted description of the degradation of PLGA is a random fragmentation that is autocatalyzed by the accumulation of acidic fragments inside the bulk material. Since mechanistic studies with lactide oligomers have concluded a chain-end scission mechanism and monolayer degradation experiments with polylactide found no accelerated degradation at lower pH, we hypothesize that the impact of acidic fragments on the molecular degradation kinetics of PLGA is overestimated. By means of the Langmuir monolayer degradation technique, the molecular degradation kinetics of PLGA at different pH could be determined. Protons did not catalyze the degradation of PLGA. The molecular mechanism at neutral pH and low pH is a combination of random and chainend-cut events, while the degradation under strongly alkaline conditions is determined by rapid chainend cuts. We suggest that the degradation of bulk PLGA is not catalyzed by the acidic degradation products. Instead, increased concentration of small fragments leads to accelerated mass loss via fast chain-end cut events. In the future, we aim to substantiate the proposed molecular degradation mechanism of PLGA with interfacial rheology.

[1]  Jian Li,et al.  Mapping intermediate degradation products of poly(lactic-co-glycolic acid) in vitro. , 2018, Journal of biomedical materials research. Part B, Applied biomaterials.

[2]  Peter J. Halley,et al.  Lifetime prediction of biodegradable polymers , 2017 .

[3]  J. Siepmann,et al.  PLGA implants: How Poloxamer/PEO addition slows down or accelerates polymer degradation and drug release , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[4]  A. Lendlein,et al.  Evaluating polymeric biomaterial–environment interfaces by Langmuir monolayer techniques , 2017, Journal of The Royal Society Interface.

[5]  A. Lendlein,et al.  Effect of diisocyanate linkers on the degradation characteristics of copolyester urethanes as potential drug carrier matrices. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  B. Lin,et al.  Humidity-dependent compression-induced glass transition of the air-water interfacial Langmuir films of poly(D,L-lactic acid-ran-glycolic acid) (PLGA). , 2015, Soft matter.

[7]  R. Braatz,et al.  A mechanistic model for drug release in PLGA biodegradable stent coatings coupled with polymer degradation and erosion. , 2015, Journal of biomedical materials research. Part A.

[8]  B. Buchholz,et al.  In vitro and in vivo degradation of poly(D, L-lactide-co-glycolide)/amorphous calcium phosphate copolymer coated on metal stents. , 2011, Journal of biomedical materials research. Part A.

[9]  A. Lendlein,et al.  Hydrolytic degradation of poly(rac‐lactide) and poly[(rac‐lactide)‐co‐glycolide] at the air–water interface , 2007 .

[10]  Juergen Siepmann,et al.  How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment. , 2005, Biomacromolecules.

[11]  W. Hennink,et al.  Hydrolytic degradation of oligo(lactic acid): a kinetic and mechanistic study , 2004 .

[12]  Wim E. Hennink,et al.  New insights into the hydrolytic degradation of poly(lactic acid): participation of the alcohol terminus , 2001 .